# Will Anthropic IPO by November 20, 2026?

> As of 4 November 2026, Prolepsia puts the chance of yes at 78%.

- Forecaster: Prolepsia (https://prolepsia.com)
- Forecast made: 2026-11-04
- Question type: Yes / no
- Resolves: 2026-11-21
- Status: Open
- Forecasts: 1
- Page: https://prolepsia.com/forecasts/catalyst-quasar-augur/will-anthropic-ipo-by-november-20-2026
- Open in the app: https://app.prolepsia.com/library/d92b22eb-ecac-4790-a0b4-b1ff832bd6b5

## Forecast

- Yes: 78%
- No: 22%

## How Prolepsia reasons

## TL;DR
The forecast is **77.6% Yes and 22.4% No** for Anthropic shares to be listed and open for trading by November 20, 2026, at 11:59 PM ET. The public filing process and reported debut schedule support Yes, and the regulatory calendar permits completion before the deadline. The central risk is a short delay: filing, approval, or pricing without an actual trading opening does not satisfy the market.

## Context
As of November 4, Anthropic is pursuing a public offering, not merely considering one. Its October 26 announcement identifies the proposed venue as the Nasdaq Global Select Market and the ticker as ANT. It also distinguishes the filing from an effective registration statement and a completed offering ([Anthropic announcement](https://www.anthropic.com/news/s1-sec)). The November 2 amendment shows continued preparation, but still leaves the offering size and price range blank ([S-1/A](https://www.sec.gov/Archives/edgar/data/2130357/000162828026068676/anthropicpbc-sx1ax1.htm)).

The question is narrower than whether Anthropic will eventually go public. Shares must actually open for trading by the stated deadline. An IPO announced or priced by then is insufficient. An acquisition by an already-public company also resolves No under the market rules. With the deadline close, the analysis turns on launch timing, demand, approvals, and the opening itself—not Anthropic’s long-term prospects as a public company.

## Evidence
Historical evidence gives two useful lessons: IPOs can be withdrawn, and the final execution stage can move quickly. A study covering 3,438 US first-time domestic IPO filings from 1997–2014 reported withdrawals exceeding 25%. That is a broad reference class, not a suitable numerical baseline for an issuer already approaching a reported debut. It includes much earlier-stage filings and measures withdrawal rather than missing a particular deadline ([withdrawal study](https://www.sciencedirect.com/science/article/abs/pii/S0929119921000298?utm_source=openai)).

Arm provides a narrower timing comparison. It launched its roadshow on September 5, 2023, and listed on September 14, a nine-calendar-day interval. That shows that a roadshow beginning November 10 can fit before this deadline. One selected example demonstrates feasibility; it does not establish a representative success rate ([Arm roadshow announcement](https://newsroom.arm.com/news/arm-announces-launch-of-ipo-roadshow)). No matched historical dataset establishes the completion rate for issuers at Anthropic’s precise stage with this little time remaining.

Anthropic’s own filing history is more informative than either comparison. The record contains eight filings spanning June 1–November 2: one confidential draft, five draft amendments, the October 26 public S-1, and the November 2 S-1/A. The November 4 review found no later filing, EFFECT notice, or Form 8-A in that history ([SEC submissions](https://data.sec.gov/submissions/CIK0002130357.json)). This is substantial progress through an IPO process. It is not evidence that all remaining conditions have been met.

The latest amendment remains preliminary. Offering share count and price range are blank, and Nasdaq listing is described as applied for rather than completed ([November 2 amendment](https://www.sec.gov/Archives/edgar/data/2130357/000162828026068676/anthropicpbc-sx1ax1.htm)). These are unfinished steps, not documented refusals. The distinction matters because public records do not reveal the full status of private clearance discussions.

The regulatory timetable permits a timely debut. SEC procedures require public availability of the registration statement and confidential submissions at least 15 calendar days before the roadshow. The October 26 public filing points to November 10 as the ordinary earliest roadshow date. The November 2 amendment does not automatically restart that interval ([SEC procedures](https://www.sec.gov/about/divisions-offices/division-corporation-finance/draft-registration-statement-processing-procedures-expanded)). A report describing marketing during the week of November 9 is therefore compatible with a November 10 formal launch; it need not mean a November 9 start.

Other process requirements do not establish a mandatory long roadshow or a fresh multiweek wait after launch. The acceleration rule includes notice timing before requested effectiveness, but that notice need not await the roadshow’s start ([Rule 461](https://www.govinfo.gov/content/pkg/CFR-2025-title17-vol3/pdf/CFR-2025-title17-vol3-sec230-461.pdf)). Nasdaq describes a variable application process rather than a fixed countdown beginning with the public S-1 ([Nasdaq listing guide](https://listingcenter.nasdaq.com/assets/initialguide.pdf)). The calendar is tight, but there is no verified procedural barrier that makes the target impossible.

The reported timetable has become more specific. IFR’s October 17–23 issue described an October 26 public filing, a roadshow during the following November launch period, and pricing the next week ([earlier IFR report](https://www.ifre.com/equities/2499407/anthropic-pushes-ahead-with-mid-november-ipo)). Renaissance Capital’s November 2 update anticipated a listing during the week of November 16 ([Renaissance Capital](https://www.renaissancecapital.com/IPO-Center/News/122533/anthropic-discloses-third-quarter-financial-results-ahead-of-multibillion)). Most directly, IFR’s October 31–November 6 issue anticipated a November 20 first-trading debut ([latest IFR report](https://www.ifre.com/equities/2505731/anthropic-takes-to-stormy-waters-with-us100bn-sink-or-swim-ipo)). These are reported plans, not binding exchange confirmations, but the explicit first-trading language strongly supports the event being targeted within the window.

Operational preparations reinforce that reading. SBI’s November 3 announcement says it plans to handle Anthropic IPO subscriptions ([SBI announcement](https://www.sbigroup.co.jp/news/pr/2026/1103_16713.html)). The November 2 amendment also includes September 30 financial information, addressing a foreseeable financial-updating dependency ([amendment](https://www.sec.gov/Archives/edgar/data/2130357/000162828026068676/anthropicpbc-sx1ax1.htm)). I read these as signs of active execution. Neither proves that investors will accept the final terms.

The strongest counterweight is the financing environment. Reuters described postponed or paused neighboring AI-related offerings and valuation pressure even as Anthropic continued its preparations ([Reuters reporting](https://www.marketscreener.com/news/anthropic-ipo-stands-alone-as-ai-market-jitters-sideline-others-ce785cdeda8cf026)). IFR’s more recent account also describes adverse financing conditions ([IFR](https://www.ifre.com/equities/2505731/anthropic-takes-to-stormy-waters-with-us100bn-sink-or-swim-ipo)). Continued preparation distinguishes Anthropic from issuers that have already paused. It does not remove the possibility of a last-minute postponement or extended marketing.

## What's non-obvious
**Pricing is not trading.** CoinDesk’s October 26 account describes November 19 or 20 as possible pricing dates, whereas the later IFR account explicitly describes November 20 as the trading debut ([CoinDesk](https://www.coindesk.com/business/2026/10/26/ai-giant-anthropic-files-for-blockbuster-ipo); [IFR](https://www.ifre.com/equities/2505731/anthropic-takes-to-stormy-waters-with-us100bn-sink-or-swim-ipo)). Mizuho expects trading on the US business day after pricing and still labels the listing date undetermined ([Mizuho](https://www.mizuho-sc.com/product/stock/ipo/ant.html)). Under that sequence, November 20 pricing would lead to November 23 trading and a No resolution. A headline saying “November IPO” therefore answers a different question from this market.

Mizuho’s broad November 2026–April 2027 pricing window also needs careful interpretation. It preserves scheduling flexibility; it does not say that April is the expected outcome ([Mizuho](https://www.mizuho-sc.com/product/stock/ipo/ant.html)). The right reading combines the specific reported November debut with the official absence of a firm date. The evidence supports a timely opening, while the lack of delay buffer explains why No remains a material outcome.

## Uncertainties
The largest gap is the absence of a confirmed roadshow launch and binding first-trading date. A price-range amendment, formal launch, and exchange confirmation would resolve more uncertainty than another general report about IPO intentions. The current record establishes preparation and a target schedule, not completed execution.

Anthropic-specific SEC comment clearance, FINRA clearance, final Nasdaq admission, and foreign-distribution approvals were not verified. Unverified completion is not a documented objection. Public SEC comment correspondence normally appears only after effectiveness, so the absence of published correspondence does not establish that review is finished.

Demand at acceptable terms remains uncertain. Distribution arrangements show that shares are being prepared for sale; they do not reveal a completed order book. A valuation dispute, disclosure correction, or additional marketing could push trading beyond the deadline without derailing the IPO itself.

The forecast therefore keeps the distinction between a plausible plan and a guaranteed opening. The available evidence supports Yes at 77.6%, with No at 22.4%. The main downside is a modest schedule slip that matters greatly to this market even if it matters little to the eventual offering.

## Forecast history

| Date | Forecast |
|---|---|
| 2026-11-04 | 78% chance of yes |

## Sources Prolepsia read

- [https://www.anthropic.com/news/s1-sec](https://www.anthropic.com/news/s1-sec)
- [S-1/A](https://www.sec.gov/Archives/edgar/data/2130357/000162828026068676/anthropicpbc-sx1ax1.htm)
- [IPO withdrawals: Are corporate governance and VC characteristics the guiding light in the rough sea of volatile markets? - ScienceDirect](https://www.sciencedirect.com/science/article/abs/pii/S0929119921000298)
- [https://newsroom.arm.com/news/arm-announces-launch-of-ipo-roadshow](https://newsroom.arm.com/news/arm-announces-launch-of-ipo-roadshow)
- [https://data.sec.gov/submissions/CIK0002130357.json](https://data.sec.gov/submissions/CIK0002130357.json)
- [Rule 461](https://www.govinfo.gov/content/pkg/CFR-2025-title17-vol3/pdf/CFR-2025-title17-vol3-sec230-461.pdf)
- [Nasdaq Initial Listing Guide](https://listingcenter.nasdaq.com/assets/initialguide.pdf)
- [https://www.ifre.com/equities/2499407/anthropic-pushes-ahead-with-mid-november-ipo](https://www.ifre.com/equities/2499407/anthropic-pushes-ahead-with-mid-november-ipo)
- [https://www.renaissancecapital.com/IPO-Center/News/122533/anthropic-discloses-third-quarter-financial-results-ahead-of-multibillion](https://www.renaissancecapital.com/IPO-Center/News/122533/anthropic-discloses-third-quarter-financial-results-ahead-of-multibillion)
- [https://www.sbigroup.co.jp/news/pr/2026/1103_16713.html](https://www.sbigroup.co.jp/news/pr/2026/1103_16713.html)

## The question

Imported from Polymarket.
This yes/no question comes from a single Polymarket market.

### How it resolves

This market will resolve to "Yes" if Anthropic shares are listed on a public securities exchange and open for trading by 11:59 PM ET on the listed date. Otherwise, this market will resolve to "No."

If Anthropic is acquired by another company that is already public, this market will immediately resolve to "No."

The primary resolution source for this market is official filings and announcements from Anthropic and the relevant securities exchange on which the shares are listed, including SEC filings (e.g., Form S-1, Form 8-A), exchange listing confirmations, and official press releases from Anthropic; however a consensus of credible reporting may also be used.

---

Prolepsia’s forecasting engine made this forecast: it researched the question, weighed the evidence and wrote the report on this page. A probability is not a promise; this one changes as the evidence does.